Education History
| Postdoctoral Training |
Dana-Farber Cancer Institute |
Postdoctoral Researcher |
|---|---|---|
| Fellowship |
Dana-Farber Cancer Institute |
Clinical Research Fellow |
| Residency |
Johns Hopkins Hospital |
Resident |
| Internship |
Johns Hopkins Hospital |
Intern |
| Professional Medical |
Schulich School of Medicine & Dentistry, Western University |
MD |
| Doctoral Training |
University of Pennsylvania |
PhD |
| Undergraduate |
University of Alberta |
BS |
Selected Publications
Journal Article
- Sun Y, Patterson-Fortin J, Han S, Li Z, Nowicka Z, Hirohashi Y, Kilgas S, Yi JK, Spektor A, Fendler W, Konstantinopoulos PA, Chowdhury D (2024). 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Nat Commun, 15(1), 6676. (Read full article)
- Patterson-Fortin J, Bose A, Tsai WC, Grochala C, Nguyen H, Zhou J, Parmar K, Lazaro JB, Liu J, McQueen K, Shapiro GI, Kozono D, DAndrea AD (2022). Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers. Cancer Res, 82(20), 3815-3829. (Read full article)
- Stein JE, Patterson-Fortin J, Bodnar BE (2018). Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis. BMJ Case Rep, 2018. (Read full article)
- Patterson-Fortin J, Harris CM, Niranjan-Azadi A, Melia M (2016). Serum sickness-like reaction after the treatment of cellulitis with amoxicillin/clavulanate. BMJ Case Rep, 2016. (Read full article)
- Patterson-Fortin J, Kohli A, Suarez MJ, Miller PE (2016). Ocular Lyme borreliosis as a rare presentation of unilateral vision loss. BMJ Case Rep, 2016. (Read full article)
- Zheng H, Gupta V, Patterson-Fortin J, Bhattacharya S, Katlinski K, Wu J, Varghese B, Carbone CJ, Aressy B, Fuchs SY, Greenberg RA (2013). A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Rep, 5(1), 180-93. (Read full article)
- Branchetti E, Sainger R, Poggio P, Grau JB, Patterson-Fortin J, Bavaria JE, Chorny M, Lai E, Gorman RC, Levy RJ, Ferrari G (2012). Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol, 33(2), e66-74. (Read full article)
- Solyom S, Aressy B, Pylks K, Patterson-Fortin J, Hartikainen JM, Kallioniemi A, Kauppila S, Nikkil J, Kosma VM, Mannermaa A, Greenberg RA, Winqvist R (2012). Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions. Sci Transl Med, 4(122), 122ra23. (Read full article)
- Patterson-Fortin J, Shao G, Bretscher H, Messick TE, Greenberg RA (2010). Differential regulation of JAMM domain deubiquitinating enzyme activity within the RAP80 complex. J Biol Chem, 285(40), 30971-81. (Read full article)
- Solyom S, Patterson-Fortin J, Pylks K, Greenberg RA, Winqvist R (2009). Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families. Breast Cancer Res Treat, 120(1), 165-8. (Read full article)
- Shao G, Patterson-Fortin J, Messick TE, Feng D, Shanbhag N, Wang Y, Greenberg RA (2009). MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev, 23(6), 740-54. (Read full article)
- Shao G, Lilli DR, Patterson-Fortin J, Coleman KA, Morrissey DE, Greenberg RA (2009). The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc Natl Acad Sci U S A, 106(9), 3166-71. (Read full article)
Review
- Patterson-Fortin J, DAndrea AD (2020). Exploiting the Microhomology-Mediated End-Joining Pathway in Cancer Therapy. [Review]. Cancer Res, 80(21), 4593-4600. (Read full article)
- Patterson-Fortin J, Moliterno AR (2017). Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender. [Review]. Curr Hematol Malig Rep, 12(5), 424-431. (Read full article)